Ad hoc:Carl Zeiss Meditec AG:Ad hoc: Carl Zeiss Meditec continues successful growth strategy with ne

(Thomson Reuters ONE) - Carl Zeiss Meditec AG / / Ad hoc: Carl Zeiss Meditec continues successful growth strategy with new Chief Executive Officer processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. JENA - 18 January 2010At today's meeting the Supervisory Board of Carl Zeiss Meditec agreed to theresignation of Dr Michael Kaschke (52) from his position on the Management Boardwith effect from the end of the Annual General Meeting on 4 March 2010. TheSupervisory Board appointed the member of the Management Board Dr Ludwin Monz(46) as the company's new Chief Executive Officer to succeed Dr Michael Kaschke.Dr Michael Kaschke intends to return to the Supervisory Board and will stand forelection at the AGM on 4 March 2010.Kaschke, then Chairman of the Supervisory Board, assumed the position of ChiefExecutive Officer of Carl Zeiss Meditec in July 2008 in compliance with Art.105 of the German Stock Corporation Act.The Supervisory Board thanks Dr Michael Kaschke for the extraordinary commitmentwith which he has made a decisive contribution to the necessary realignment ofCarl Zeiss Meditec.Dr Ludwin Monz has been a member of the Management Board of Carl Zeiss MeditecAG since October 2007, where he has been responsible for the strategic businessunit Ophthalmic Systems. The other members of the Management Board of Carl ZeissMeditec are Dr Christian M?r and Ulrich Krauss.Contact: Eva Sesselmann Patrick Kofler Director Corporate Communications Director Investor Relations Carl Zeiss Meditec AG Carl Zeiss Meditec AG G?witzer Stra? 51-52 G?witzer Stra? 51-52 07745 Jena 07745 Jena Telephone: +49 3641 220-331 Telephone: +49 3641 220-106 Fax: +49 3641 220-112 Fax: +49 3641 220-117 E-mail: press(at)meditec.zeiss.com E-mail: investors(at)meditec.zeiss.com Brief profileCarl Zeiss Meditec AG, listed in the TecDAX at the German Stock Exchange (ISINDE0005313704), is one of the world's leading medical technology suppliers.The company markets innovative technologies and application-oriented solutionsto enable physicians to improve the quality of life of their patients. For thediagnosis and treatment of eye ailments the company offers all-in-one solutionsincluding implants and consumables.In the field of microsurgery the company supplies innovative visualisationsolutions. Promising future technologies such as intraoperative radiationtherapy round off the medical technology portfolio of Carl Zeiss Meditec.In financial year 2008/09 (30 September) a workforce of about 2,100 generated aturnover of EUR 640 million. The head office of Carl Zeiss Meditec is at Jena inGermany. In addition to further subsidiaries in Germany over 50% of thecompany's employees are located in the USA, Japan, Spain and France.Thirty-five percent of the Carl Zeiss Meditec shares are in free float. Theremaining 65 percent are held by Carl Zeiss, one of the world's leading groupsengaged in the optical and opto-electronics industry. Carl Zeiss offersinnovative solutions for the future markets Medical & Research Solutions,Industrial Solutions and Lifestyle Products. The headquarters of Carl Zeiss AGare located at Oberkochen, Germany. In financial year 2008/09 (balance sheetdate 30 September) the Group generated sales of about EUR 2.1 billion. Carl Zeissemploys almost 13,000 persons, over 8,000 of them in GermanyFor further information visit: www.meditec.zeiss.de[HUG#1374528] --- End of Message --- Carl Zeiss Meditec AGGoeschwitzer Strasse 51-52 Jena GermanyWKN: 531370;ISIN: DE0005313704;Index:TECH All Share,TecDAX,Prime All Share;Listed: Freiverkehr in B? Stuttgart,Freiverkehr in Hanseatische Wertpapierb? zu Hamburg,Freiverkehr in B? Berlin,Freiverkehr in B? D?ldorf,Freiverkehr in Bayerische B? M?en,Freiverkehr in Nieders?sische B? zu Hannover,Prime Standard in Frankfurter Wertpapierb?,Regulierter Markt in Frankfurter Wertpapierb?;

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Leseranfragen:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: hugin
Datum: 18.01.2010 - 12:21 Uhr
Sprache: Deutsch
News-ID 1008997
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

Jena

Phone:

Kategorie:

Business News

Anmerkungen:


Diese Pressemitteilung wurde bisher 117 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ad hoc:Carl Zeiss Meditec AG:Ad hoc: Carl Zeiss Meditec continues successful growth strategy with ne
"
steht unter der journalistisch-redaktionellen Verantwortung von

Carl Zeiss Meditec AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Alle Meldungen von Carl Zeiss Meditec AG